a b s t r a c t
Cerebral amyloid beta (A␤) deposition occurs in a substantial fraction of cognitively normal (CN) older individuals. However, it has been difficult to reliably detect evidence of amyloid-related cognitive alterations in CN using standard neuropsychological measures. We sought to determine whether a highly demanding face-name associative memory exam (FNAME) could detect evidence of A␤-related memory impairment in CN. We studied 45 CN subjects (mean age = 71.7 ± 8.8) with Clinical Dementia Rating (CDR) scores = 0 and MMSE ≥ 28, using Positron Emission Tomography with Pittsburgh Compound B (PiB PET). Memory factor scores were derived from a principal components analysis for FNAME name retrieval (FN-N), FNAME occupation retrieval (FN-O) and the 6-Trial Selective Reminding Test (SRT). Using multiple linear and logistic regression analyses, we related the memory factor scores to PiB distribution volume ratios (DVR, cerebellar reference) as either a continuous or a dichotomous variable in frontal cortex and a posterior cortical region representing the precuneus, posterior cingulate and lateral parietal cortices (PPCLP), co-varying for age and AMNART IQ (a proxy of cognitive reserve (CR)). A significant inverse relationship for FN-N was found with A␤ deposition in frontal (R 2 = 0.29, ˇ = −2.2, p = 0.02) and PPCLP cortices (R 2 = 0.26, ˇ = −2.4, p = 0.05). In contrast, neither FN-O nor the SRT were significantly related to A␤ deposition. Performance on a demanding test of face-name associative memory was related to A␤ burden in brain regions associated with memory systems. Associative memory for faces and names, a common complaint among older adults, may be a sensitive marker of early A␤-related impairment.
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Introduction
Cognitively normal (CN) older individuals without evidence of cognitive or functional impairment are frequently found to harbor a substantial burden of fibrillar amyloid beta (A␤) pathology when imaged with Positron Emission Tomography (PET) using Pittsburgh Compound B (PiB) (Fagan et al., 2006; Johnson, 2006; Mintun et al., 2006) . This observation is consistent with postmortem data indicating that substantial numbers of A␤ plaques are found in some individuals who showed no evidence of memory impairment or dementia during their lifetime (Bennett et al., 2006; Katzman et al., 1989; Price & Morris, 1999) . Such individuals may represent a preclinical stage of Alzheimer's disease (AD) (Morris et al., 2009; Sperling et al., 2011) , however, it has been difficult to reliably detect evidence of A␤-related cognitive alternations in CN subjects using standard neuropsychological measures.
Several studies examining increased A␤ deposition with PiB PET imaging in CN subjects were unable to find a relationship between cognitive test performance and A␤ burden (Aizenstein et al., 2008; Jack et al., 2008; Mormino et al., 2009; Villemagne et al., 2011) . One study (Pike et al., 2007) of 32 healthy control subjects was able to find a modest relationship (r = −0.38) between A␤ burden and episodic memory (EM) in CN subjects but the general findings were limited by sample selection bias toward family history and the presence of an apolipoprotein (APOE) 4 allele, primary risk factors for AD. Another study by Mormino et al. (2009) found that PiB retention was related to EM and to hippocampal volume (HV) in a subset (N = 20) of the healthy control subjects studied. However, when HV and PiB were included in a regression model predicting EM, the HV variable was significant and the PiB variable was not. Storandt, Mintun, Head, and Morris (2009) reported an association of A␤ burden with longitudinal cognitive decline prior to diagnosis of AD but a single time point of cognitive performance was not predictive of A␤-related cognitive change.
